Related Experiment Video
Updated: Jun 5, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Ras effector switching promotes divergent cell fates in C. elegans vulval patterning
Tanya P Zand1, David J Reiner, Channing J Der
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Abstract:
The C. elegans vulva is patterned by epidermal growth factor (EGF) activation of Ras to control 1° fate, and 1° fate induces antagonistic Notch-dependent 2° fate. Furthermore, a spatial EGF gradient, in addition to inducing 1° fate, directly contributes to 2° fate via an unknown pathway. We find that in addition to its canonical effector, Raf, vulval Ras utilizes an exchange factor for the Ral small GTPase (RalGEF), such that Ras-RalGEF-Ral antagonizes Ras-Raf pro-1° fate activity. Consistent with its restricted expression pattern, Ral participates in EGF pro-2° activity. Thus, we have delineated a Ras effector-switching mechanism whereby position within the morphogen gradient dictates that Ras effector usage is switched to RalGEF from Raf to promote 2° instead of 1° fate. Our observations define the utility of Ras effector switching during normal development and may provide a possible mechanistic basis for cell and cancer-type differences in effector dependency and activation.
Related Concept Videos
Cell Polarization by Rho Proteins
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Position-effect Variegation
Cis-regulatory Sequences
Cytoskeletal Coordination in Cell Migration
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

